AstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns

In December 2020, pharma giant AstraZeneca (AZ) announced its intention to acquire biopharmaceutical company Alexion. The merger would give AZ an increased portfolio in rare disease and immunology. While the US Federal Trade Commission (FTC) has approved the merger, several...

1 week ago
Investment,Biology,News

AstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns

In December 2020, pharma giant AstraZeneca (AZ) announced its intention to acquire biopharmaceutical company Alexion. The merger would give AZ an increased portfolio in rare disease and immunology. While the US Federal Trade Commission (FTC) has approved the merger, several...

1 week ago

The Great Debate: The Utilisation of True AI in All Aspects of Drug Discovery

As a part of Proventa’s Medicinal Chemistry and Biology Strategy Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Gilead’s Executive Director for...

2 weeks ago
R&D,Biology,News

The Great Debate: The Utilisation of True AI in All Aspects of Drug Discovery

As a part of Proventa’s Medicinal Chemistry and Biology Strategy Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Gilead’s Executive Director for...

2 weeks ago

Biomarker Discovery and Validation: Current Challenges in Oncology

Biomarkers have shown significant potential across oncology clinical studies, especially in precision medicine for immunotherapy. Therefore, it is important that biomarker discovery and validation is optimised to produce the most effective drugs for patient populations. False positives and experimental bias...

2 weeks ago
Oncology,R&D,Biology,News

Biomarker Discovery and Validation: Current Challenges in Oncology

Biomarkers have shown significant potential across oncology clinical studies, especially in precision medicine for immunotherapy. Therefore, it is important that biomarker discovery and validation is optimised to produce the most effective drugs for patient populations. False positives and experimental bias...

2 weeks ago

First Potential Alzheimer’s Drug on the Brink of FDA Approval

On 7 June 2021, Biogen will receive an answer from the FDA regarding the approval of their Alzheimer’s drug, Aducanumab. Approval for this drug will represent a significant milestone in disease management for Alzheimer’s patients, in terms of slowing the...

2 weeks ago
R&D,Clinical Development,Biology,News

First Potential Alzheimer’s Drug on the Brink of FDA Approval

On 7 June 2021, Biogen will receive an answer from the FDA regarding the approval of their Alzheimer’s drug, Aducanumab. Approval for this drug will represent a significant milestone in disease management for Alzheimer’s patients, in terms of slowing the...

2 weeks ago

Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health

COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...

2 weeks ago
Clinical Operations,Race and Ethics,Precision and Personalised Medicine,Biology,News

Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health

COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...

2 weeks ago

Exploring the Latest Therapeutic Tools and In Vitro Technologies

Preclinical studies are an integral part of drug development in terms of screening drug candidates for therapeutic efficacy and potential toxic events. 3D culture and organ-on-chip technology are a few examples of the innovations in in vitro/in vivo modelling to...

2 weeks ago
R&D,Biology,News

Exploring the Latest Therapeutic Tools and In Vitro Technologies

Preclinical studies are an integral part of drug development in terms of screening drug candidates for therapeutic efficacy and potential toxic events. 3D culture and organ-on-chip technology are a few examples of the innovations in in vitro/in vivo modelling to...

2 weeks ago
Previous Page Showing 12 out of 139 Next Page
Working With us

Interested?
Reserve your space